143 related articles for article (PubMed ID: 23664158)
1. Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom.
Mendes TM; Oliveira D; Figueiredo LF; Machado-de-Avila RA; Duarte CG; Dias-Lopes C; Guimarães G; Felicori L; Minozzo JC; Chávez-Olortegui C
Vaccine; 2013 Jun; 31(25):2749-55. PubMed ID: 23664158
[TBL] [Abstract][Full Text] [Related]
2. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes.
Felicori L; Fernandes PB; Giusta MS; Duarte CG; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
Vaccine; 2009 Jun; 27(31):4201-8. PubMed ID: 19389441
[TBL] [Abstract][Full Text] [Related]
3. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Protein Containing B-Cell Epitopes of Different
Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Front Immunol; 2018; 9():653. PubMed ID: 29666624
[TBL] [Abstract][Full Text] [Related]
5. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
[TBL] [Abstract][Full Text] [Related]
7. Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders.
Souza NA; Dias-Lopes C; Matoso ÍHG; de Oliveira CFB; Chávez-Olortegui CD; Minozzo JC; Felicori LF
Vaccine; 2018 Nov; 36(48):7324-7330. PubMed ID: 30352745
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
10. Protective antibodies against a sphingomyelinase D from Loxosceles intermedia spider venom elicited in mice with different genetic background.
Oliveira CF; Vilela A; Coura LA; Rodrigues FT; Nagem RA; Chávez-Olortegui C; Maioli TU; Felicori LF
Vaccine; 2016 Jul; 34(33):3828-34. PubMed ID: 27265457
[TBL] [Abstract][Full Text] [Related]
11. Engineered antigen containing epitopes from Loxosceles spp. spider toxins induces a monoclonal antibody (Lox-mAb3) against astacin-like metalloproteases.
Costa TGF; Costal-Oliveira F; de Assis TCS; Lima SA; Martins CA; Finco AB; Veiga SS; Soccol VT; Machado-de-Ávila RA; Figueiredo LFM; Minozzo JC; Kalapothakis E; Guerra-Duarte C; Alvarenga LM; Chávez-Olórtegui C
Int J Biol Macromol; 2020 Nov; 162():490-500. PubMed ID: 32574737
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
Guilherme P; Fernandes I; Barbaro KC
Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
[TBL] [Abstract][Full Text] [Related]
13. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom.
Kalapothakis E; Araujo SC; de Castro CS; Mendes TM; Gomez MV; Mangili OC; Gubert IC; Chávez-Olórtegui C
Toxicon; 2002 Dec; 40(12):1691-9. PubMed ID: 12457881
[TBL] [Abstract][Full Text] [Related]
15. Identification, cloning and functional characterization of a novel dermonecrotic toxin (phospholipase D) from brown spider (Loxosceles intermedia) venom.
Appel MH; da Silveira RB; Chaim OM; Paludo KS; Silva DT; Chaves DM; da Silva PH; Mangili OC; Senff-Ribeiro A; Gremski W; Nader HB; Veiga SS
Biochim Biophys Acta; 2008 Feb; 1780(2):167-78. PubMed ID: 18082635
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
17. A protective immune response against lethal, dermonecrotic and hemorrhagic effects of Loxosceles intermedia venom elicited by a 27-residue peptide.
Dias-Lopes C; Guimarães G; Felicori L; Fernandes P; Emery L; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
Toxicon; 2010; 55(2-3):481-7. PubMed ID: 19818803
[TBL] [Abstract][Full Text] [Related]
18. Brown spider dermonecrotic toxin directly induces nephrotoxicity.
Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S
Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484
[TBL] [Abstract][Full Text] [Related]
19. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
[TBL] [Abstract][Full Text] [Related]
20. Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides.
de Moura J; Felicori L; Moreau V; Guimarães G; Dias-Lopes C; Molina L; Alvarenga LM; Fernandes P; Frézard F; Ribeiro RR; Fleury C; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
Vaccine; 2011 Oct; 29(45):7992-8001. PubMed ID: 21872636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
